Terumo (Terumo) Additional Paid-In Capital : $359 Mil(As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Terumo Additional Paid-In Capital?

Terumo's quarterly additional paid-in capital declined from Jun. 2023 ($367 Mil) to Sep. 2023 ($349 Mil) but then increased from Sep. 2023 ($349 Mil) to Dec. 2023 ($359 Mil).

Terumo's annual additional paid-in capital declined from Mar. 2021 ($477 Mil) to Mar. 2022 ($438 Mil) and declined from Mar. 2022 ($438 Mil) to Mar. 2023 ($387 Mil).

Terumo Additional Paid-In Capital Historical Data

The historical data trend for Terumo's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Terumo Additional Paid-In Capital Chart

Terumo Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Additional Paid-In Capital

Get a 7-Day Free Trial

468.12

481.65

476.81

437.87

387.23

Terumo Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															384.96	387.23	366.60	349.22	359.00

Terumo Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Terumo Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Terumo's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Terumo (Terumo) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Terumo Corp (OTCPK:TRUMY) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

TRUMF:USA 4543:Japan TUO:Germany

Address

2-44-1 Hatagaya, Shibuya-ku, Tokyo, JPN, 151-0072

Website

https://www.terumo.com

Terumo Corp manufactures and sells medical products and equipment. The firm has three main businesses: blood management, cardiac and vascular, and general hospital. The cardiac and vascular business generates the largest proportion of revenue and sells cardiac and endovascular interventional therapies, cardiovascular surgical systems, neurovascular products, and vascular graft products. The general hospital business includes diabetes management, consumer healthcare, drug and device technologies, and general hospital products. The blood management business sells blood component, therapeutic apheresis, and cellular technologies. Terumo generates the majority of its revenue in Asia, with Japan contributing the largest proportion of Asian revenue.